Overview

Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
There is a growing body of evidence in the literature regarding the adverse effects of hyperglycemia in critically ill patients. To target and maintain better blood glucose regulation we implemented an insulin protocol with target blood glucose levels between 81-110 mg/dL.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Ghent
Treatments:
Insulin
Insulin, Globin Zinc